Zai Lab (ZLAB) Operating Margin (2019 - 2026)
Zai Lab (ZLAB) reported Operating Margin of 1711.1% for Q1 2026, down 165780.0% on a YoY basis from N/an in Q1 2025, and down 8225.41% sequentially from 21.06% in Q4 2025.
Zai Lab (ZLAB) Operating Margin (2019 - 2026) Analysis & Trends
Zai Lab (ZLAB) has 7 years of Operating Margin data on file, last reported at 1711.1% in Q1 2026.
- For the quarter ending Q1 2026, Operating Margin fell 165780.0% year-over-year to 1711.1%; the trailing twelve-month figure through Mar 2026 stood at 74.86% (up 15913.0% YoY), and the FY2025 full-year result was 7714.66%, down 764395.0% from the prior year.
- Operating Margin eased to 1711.1% in Q1 2026, from 21.06% in the prior quarter.
- In the past five years, Operating Margin ranged from a high of 21.06% in Q4 2025 to a low of 19111.56% in Q2 2024.
- A 5-year average of 2198.37% and a median of 138.77% in 2023 frame the typical range for Operating Margin.
- Peak annual rise in Operating Margin reached 1301211 bps in 2025, while the deepest fall reached 690822 bps in 2025.
- Tracing ZLAB's Operating Margin over 5 years: stood at 156.83% in 2022, then soared by 70 bps to 46.48% in 2023, then plunged by 33 bps to 61.78% in 2024, then soared by 134 bps to 21.06% in 2025, then tumbled by 8225 bps to 1711.1% in 2026.
- Business Quant data shows ZLAB's Operating Margin at 1711.1% in Q1 2026, 21.06% in Q4 2025, and 6974.57% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 16.51% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 38.10% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 17.83% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 31.68% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Zai Lab | 22.02 Bn | 22.02 Bn | 61.30 Mn | -69.66% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -69.66% |
| Dec 31, 2025 | -54.39% |
| Sep 30, 2025 | -42.05% |
| Jun 30, 2025 | -49.91% |
| Mar 31, 2025 | -52.88% |
| Dec 31, 2024 | -62.25% |
| Sep 30, 2024 | -66.35% |
| Jun 30, 2024 | -75.68% |
| Mar 31, 2024 | -80.68% |
| Dec 31, 2023 | -188.34% |
| Sep 30, 2023 | -120.72% |
| Jun 30, 2023 | -129.97% |
| Mar 31, 2023 | -110.71% |
| Dec 31, 2022 | -155.42% |
| Sep 30, 2022 | -223.47% |
| Jun 30, 2022 | -204.91% |
| Mar 31, 2022 | -170.71% |
| Dec 31, 2021 | -498.58% |
| Sep 30, 2021 | -193.04% |
| Jun 30, 2021 | -461.81% |